Search research articles
Contact Us
Filters
Showing results (81-90 of 108) with videos related to
Page
of 11
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
June 18, 2010
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
Eva Tiensuu Janson, Halfdan Sørbye, Staffan Welin, et al.
Diagnostics (Basel, Switzerland)
|
April 23, 2022
First-in-Human Study of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET for Integrin α<sub>v</sub>β<sub>3</sub> Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety, Dosimetry and Tumor Imaging Ability
Malene Martini Clausen, Esben Andreas Carlsen, Camilla Christensen, et al.
Medical Oncology (Northwood, London, England)
|
March 8, 2018
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Abir Salwa Ali, Malin Grönberg, Seppo W Langer, et al.
EJNMMI Research
|
May 28, 2022
A convolutional neural network for total tumor segmentation in [<sup>64</sup>Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms
Esben Andreas Carlsen, Kristian Lindholm, Amalie Hindsholm, et al.
Plos One
|
February 12, 2015
Goblet cell carcinoids: characteristics of a Danish cohort of 83 patients
Ingrid Holst Olsen, Nanna Holt, Seppo W Langer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2015
64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
Andreas Pfeifer, Ulrich Knigge, Tina Binderup, et al.
Journal of Neuroendocrinology
|
March 19, 2026
Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours
Stefano Partelli, Detlef K Bartsch, Massimo Falconi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 3, 2021
A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for <sup>68</sup>Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
Irene Virgolini, Shadfar Bahri, Andreas Kjaer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 24, 2020
<sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
Mathias Loft, Esben A Carlsen, Camilla B Johnbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 12, 2012
Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study
Andreas Pfeifer, Ulrich Knigge, Jann Mortensen, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 108) with videos related to
Sort By:
Page
of 11
Acta Oncologica (Stockholm, Sweden)
|
June 18, 2010
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours
Eva Tiensuu Janson, Halfdan Sørbye, Staffan Welin, et al.
Diagnostics (Basel, Switzerland)
|
April 23, 2022
First-in-Human Study of [<sup>68</sup>Ga]Ga-NODAGA-E[c(RGDyK)]<sub>2</sub> PET for Integrin α<sub>v</sub>β<sub>3</sub> Imaging in Patients with Breast Cancer and Neuroendocrine Neoplasms: Safety, Dosimetry and Tumor Imaging Ability
Malene Martini Clausen, Esben Andreas Carlsen, Camilla Christensen, et al.
Medical Oncology (Northwood, London, England)
|
March 8, 2018
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
Abir Salwa Ali, Malin Grönberg, Seppo W Langer, et al.
EJNMMI Research
|
May 28, 2022
A convolutional neural network for total tumor segmentation in [<sup>64</sup>Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms
Esben Andreas Carlsen, Kristian Lindholm, Amalie Hindsholm, et al.
Plos One
|
February 12, 2015
Goblet cell carcinoids: characteristics of a Danish cohort of 83 patients
Ingrid Holst Olsen, Nanna Holt, Seppo W Langer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2015
64Cu-DOTATATE PET for Neuroendocrine Tumors: A Prospective Head-to-Head Comparison with 111In-DTPA-Octreotide in 112 Patients
Andreas Pfeifer, Ulrich Knigge, Tina Binderup, et al.
Journal of Neuroendocrinology
|
March 19, 2026
Controversies in neuroendocrine neoplasms: An European Neuroendocrine Tumor Society position statement on the role of surgery of the primary tumour in metastatic small intestinal and pancreatic neuroendocrine tumours
Stefano Partelli, Detlef K Bartsch, Massimo Falconi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 3, 2021
A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for <sup>68</sup>Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
Irene Virgolini, Shadfar Bahri, Andreas Kjaer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 24, 2020
<sup>64</sup>Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
Mathias Loft, Esben A Carlsen, Camilla B Johnbeck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 12, 2012
Clinical PET of neuroendocrine tumors using 64Cu-DOTATATE: first-in-humans study
Andreas Pfeifer, Ulrich Knigge, Jann Mortensen, et al.
Page
of 11